Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...

The newly-launched once-weekly basal insulin, Awiqli (insulin icodec by Novo Nordisk) is another therapeutic option that may ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the treatment of type 1 and type 2 diabetes in adults ...

Awiqli is the world's first once-a-week basal insulin injection ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9–13 Sept) shows that a ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels, ...

The MarketWatch News Department was not involved in the creation of this content. -- Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may now need just one injection a week.

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for eligible adults with diabetes. Experts explain how it works, who may ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...